Hormone Receptor Positive HER-2 Negative Breast Cancer trials recruiting in Connecticut

Fewer than 3 recruiting trials found.

All Hormone Receptor Positive HER-2 Negative Breast Cancer trials nationally

Cities in Connecticut

Recruiting trials in Connecticut

• A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
  NCT06369285 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: New Haven
• Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer
  NCT05573126 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Female · Connecticut: New Haven